GlassScriptPhysician profile
Turna Mukherjee
NPI 1952806374
$6,367.43
in general payments reported to CMS, 2019-2025
9 companies · $551 in 2025
The $551 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.68 · 2022: $1,901 · 2023: $1,657 · 2024: $2,245 · 2025: $551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,473 · Travel and Lodging: $979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,473.34 |
| Travel and Lodging | $978.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $3,118.30 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Philips North America LLC | $1,259.39 | 2022 | |
| Cook Medical LLC | $670.70 | 2023-2024 | Zilver Ptx, Zenith, Zilver Vena |
| Boston Scientific Corporation | $573.08 | 2021-2025 | Eluvia |
| Stryker Corporation | $274.49 | 2025 | Limflow System, Citrefix, Flexband |
| Penumbra, INC. | $246.18 | 2023-2025 | Indigo System, Smart Coil |
| Silk Road Medical, INC. | $125.17 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Bard Peripheral Vascular, INC. | $73.56 | 2024 | Crosser Iq |
| Lemaitre Vascular, INC. | $26.56 | 2024 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Turna Mukherjee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.